Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2010 Mar;65(3):201-7.
doi: 10.1136/thx.2009.122291. Epub 2009 Oct 12.

Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia

Affiliations
Multicenter Study

Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia

Andrew Conway Morris et al. Thorax. 2010 Mar.

Erratum in

  • Thorax. 2010 Sep;65(9):844

Abstract

Background: Ventilator-associated pneumonia (VAP) is the most commonly fatal nosocomial infection. Clinical diagnosis of VAP remains notoriously inaccurate. The hypothesis was tested that significantly augmented inflammatory markers distinguish VAP from conditions closely mimicking VAP.

Methods: A prospective, observational cohort study was carried out in two university hospital intensive care units recruiting 73 patients with clinically suspected VAP, and a semi-urban primary care practice recruiting a reference group of 21 age- and sex-matched volunteers. Growth of pathogens at >10(4) colony-forming units (cfu)/ml of bronchoalveolar lavage fluid (BALF) distinguished VAP from "non-VAP". Inflammatory mediators were quantified in BALF and serum. Mediators showing significant differences between patients with and without VAP were analysed for diagnostic utility by receiver operator characteristic (ROC) curves.

Results: Seventy-two patients had recoverable lavage-24% had VAP. BALF interleukin-1beta (IL-1beta), IL-8, granulocyte colony-stimulating factor and macrophage inflammatory protein-1alpha were significantly higher in the VAP group (all p<0.005). Using a cut-off of 10 pg/ml, BALF IL-1beta generated negative likelihood ratios for VAP of 0.09. In patients with BALF IL-1beta <10 pg/ml the post-test probability of VAP was 2.8%. Using a cut-off value for IL-8 of 2 ng/ml, the positive likelihood ratio was 5.03. There was no difference in cytokine levels between patients with sterile BALF and those with growth of <10(4) cfu/ml.

Conclusions: BALF IL-1beta and IL-8 are amongst the strongest markers yet identified for accurately demarcating VAP within the larger population of patients with suspected VAP. These findings have potential implications for reduction in unnecessary antibiotic use but require further validation in larger populations.

PubMed Disclaimer

Conflict of interest statement

Competing interests: ACM has received an academic prize (travel and accommodation to attend an international conference) funded by Eli Lily. AJS has received expenses from Astra Zeneca and Glaxo Smith Kline (for travel and accommodation) to attend international educational conferences. IFL has received expenses from Astra Zeneca (for travel and accommodation) to attend international educational conferences. TSW is the recipient of an unrestricted educational grant from Wyeth Pharmaceuticals for work concerning epidemiology of ICU-acquired infection. All other authors have no conflicts of interest to declare

Figures

Figure 1
Figure 1
Receiver operating characteristic (ROC) curves and optimal sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPVs) for bronchoalveolar lavage fluid (BALF) cytokines (n=72, 55 non-ventilator-associated pneumonia (VAP) and 17 VAP). Data are derived from the patients with clinically suspected VAP. The broken line shows identity. G-CSF, granulocyte colony-stimulating factor; IL, interleukin; +LR, positive likelihood ratio; −LR, negative likelihood ratio; MIP 1-α, macrophage inflammatory protein-1α; sTREM-1; type 1 soluble triggering receptor expressed on myeloid cells.
Figure 2
Figure 2
Scatter plots of pulmonary cytokine levels (n=72, 55 non-ventilator-associated pneumonia (VAP) and 17 VAP). Each dot represents a single observation. The solid lines mark the median values; the hashed line marks the optimal diagnostic cut-off. A log scale is used due to the skewed nature of cytokine levels. G-CSF, granulocyte colony-stimulating factor; IL, interleukin; MIP1-α, macrophage inflammatory protein-1α;
Figure 3
Figure 3
Comparison of pulmonary cytokine levels between patients with ventilator-associated pneumonia (VAP) (n=17), patients with growth of pathogens in bronchoalveolar lavage fluid (BALF) below the diagnostic 104 cfu/ml cut-off (n=22), and patients with no growth in BALF (n=33). (A) Interleukin-8 (IL-8) levels. Data are presented as the median and IQRs, p<0.0001 by Kruskal–Wallis; NS (non-significant), p>0.05, **p<0.01,***p<0.0001 by the Dunn posthoc test. (B) IL-1β levels. Data are presented as the median and IQRs, p=0.0006 by Kruskal–Wallis; NS, p>0.05, **p<0.01,***p<0.0001 by the Dunn posthoc test.

Comment in

References

    1. Chastre J, Fagon J-Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;65:867–903 - PubMed
    1. Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993;270:1965–70 - PubMed
    1. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115–21 - PubMed
    1. Kollef MH, Morrow LE, Niederman MS, et al. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest 2006;129:1210–18 - PubMed
    1. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994;106:221–35 - PubMed

Publication types